Bioequivalence and Pharmacokinetic Study of Ranazoline in Healthy Male Volunteers: An Open label, Randomized, Single-Dose, Two-Way Crossover Study

MAY 2015 ARTICLE LIST >>

PharmaTutor (May- 2015)

Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 5)

Received On: 23/02/2015; Accepted On: 10/03/2015; Published On: 01/05/2015

AUTHORS: Suresh VV Babu¹, Talasila EGK Murthy²*, Chimakurthy Jithendra^3
1Dept. of Pharmaceutics, Natco Pharma Limited, Hyderabad, Telangana, India.
²Dept. of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India.
³Dept. of Pharmacology, Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India.
*drgkm@bcop.net

ABSTRACT: The present study was to assess the relative bioavailability and pharmacokinetic properties of extended release formulations of Ranolazine 1000 mg in healthy male volunteers using a randomized, open-label, balanced, twotreatment, two-period, two sequence, single dose, crossover, bioequivalence study under fasting conditions. Bioavailability of the test product of Ranolazine extended release tablets 1000 mg was compared with that of the reference product of Ranexa® (Ranolazine extended release tablets 1000mg) of CV Therapeutics Inc., California. The plasma samples were collected at 0.50, 1.00, 1.50, 2.00, 2.50, 3.00, 3.50, 4.00, 4.50, 5.00, 5.50, 6.00, 6.50, 7.00, 8.00, 10.00, 12.00, 16.00, 24.00 and 48.00 hours post dose after single administration of Ranolazine 1000mg. The plasma Ranolazine concentrations were estimated by using a validated bioanalytical method by LC-MS/MS. A ten day washout period is followed between two treatments. The formulations were considered to be bioequivalent if the 90% CIs for the log-transformed values were within the predetermined equivalence range 80%–125% for AUC and C_max. For Ranolazine, at 90% confidence intervals C_max, AUC_0-t and AUC_0-∞ were 83.43-113.29, 82.10-102.87 and 80.94-101.85 for log-transformed data respectively. The present results show that the formulation of Ranolazine was bioequivalent to the reference in fasting, healthy, male volunteers.

How to cite this article: SVV Babu, TEGK Murthy, C Jithendra; Bioequivalence and Pharmacokinetic Study of Ranazoline in Healthy Male Volunteers: An Open label, Randomized, Single-Dose, Two-Way Crossover Study; PharmaTutor; 2015; 3(5); 24-28

[ABSTRACT WITH CITATION]   [VIEW AS HTML]